Deutsche Bank
EDIT icon

Deutsche Bank’s Editas Medicine EDIT Stock Holding History

Deutsche Bank’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-79,286
Closed -$275K – 3649
2025
Q3 		$275K Buy
79,286
+9,717
+14% +$27.1K ﹤0.01% 2898
2025
Q2 		$153K Buy
+69,569
New +$114K ﹤0.01% 3080
2024
Q4 		– Sell
-88,578
Closed -$302K – 3632
2024
Q3 		$302K Buy
88,578
+14,326
+19% +$62.4K ﹤0.01% 2722
2024
Q2 		$347K Sell
74,252
-6,458
-8% -$36.4K ﹤0.01% 2528
2024
Q1 		$599K Buy
80,710
+1,023
+1% +$8.5K ﹤0.01% 2263
2023
Q4 		$807K Buy
79,687
+7,725
+11% +$67.8K ﹤0.01% 2133
2023
Q3 		$561K Buy
71,962
+4,651
+7% +$39.9K ﹤0.01% 2083
2023
Q2 		$554K Sell
67,311
-135,028
-67% -$1.18M ﹤0.01% 2303
2023
Q1 		$1.47M Sell
202,339
-58,287
-22% -$518K ﹤0.01% 1860
2022
Q4 		$2.31M Buy
260,626
+184,682
+243% +$2.03M ﹤0.01% 1570
2022
Q3 		$929K Sell
75,944
-44
-0.1% -$686 ﹤0.01% 2015
2022
Q2 		$899K Sell
75,988
-5,066
-6% -$67.9K ﹤0.01% 2254
2022
Q1 		$1.54M Sell
81,054
-6,292
-7% -$117K ﹤0.01% 2050
2021
Q4 		$2.32M Sell
87,346
-4,423
-5% -$152K ﹤0.01% 1905
2021
Q3 		$3.77M Buy
91,769
+44,560
+94% +$2.44M ﹤0.01% 1683
2021
Q2 		$2.67M Sell
47,209
-13,829
-23% -$511K ﹤0.01% 1964
2021
Q1 		$2.56M Buy
61,038
+7,974
+15% +$454K ﹤0.01% 1986
2020
Q4 		$3.72M Buy
53,064
+14,252
+37% +$585K ﹤0.01% 1519
2020
Q3 		$1.09M Sell
38,812
-977
-2% -$31.8K ﹤0.01% 2136
2020
Q2 		$1.18M Buy
39,789
+17,484
+78% +$457K ﹤0.01% 2114
2020
Q1 		$442K Sell
22,305
-222,290
-91% -$5.61M ﹤0.01% 2544
2019
Q4 		$7.24M Sell
244,595
-2,581
-1% -$64.5K ﹤0.01% 1240
2019
Q3 		$5.62M Sell
247,176
-45,399
-16% -$1.12M ﹤0.01% 1336
2019
Q2 		$7.24M Sell
292,575
-317,777
-52% -$7.59M ﹤0.01% 1573
2019
Q1 		$14.9M Buy
610,352
+187,386
+44% +$4.24M 0.01% 1137
2018
Q4 		$9.62M Sell
422,966
-299,806
-41% -$8.16M 0.01% 1329
2018
Q3 		$23M Buy
722,772
+269,119
+59% +$8.7M 0.01% 1054
2018
Q2 		$16.3M Sell
453,653
-43,027
-9% -$1.52M 0.01% 1332
2018
Q1 		$16.5M Buy
496,680
+351,154
+241% +$12.5M 0.01% 1242
2017
Q4 		$4.47M Buy
145,526
+41,206
+39% +$1.04M ﹤0.01% 2115
2017
Q3 		$2.5M Buy
104,320
+61,530
+144% +$1.17M ﹤0.01% 2389
2017
Q2 		$717K Buy
42,790
+41,136
+2,487% +$741K ﹤0.01% 3237
2017
Q1 		$36K Sell
1,654
-2,890
-64% -$59.9K ﹤0.01% 4323
2016
Q4 		$72K Sell
4,544
-55,798
-92% -$847K ﹤0.01% 4221
2016
Q3 		$813K Buy
60,342
+43,680
+262% +$895K ﹤0.01% 2955
2016
Q2 		$405K Buy
16,662
+12,051
+261% +$407K ﹤0.01% 3407
2016
Q1 		$159K Buy
+4,611
New +$121K ﹤0.01% 3757

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Deutsche Bank's EDIT Position: Q4 2025 in Review

Deutsche Bank sold out of Editas Medicine (EDIT) in Q4 2025, closing a stake of 79,286 shares — an estimated $275K sold.

Deutsche Bank first reported a position in EDIT in Q1 2016 and held it in 37 quarters. The position peaked at $23M in Q3 2018. 196 funds tracked by Wall St. Rank hold EDIT as of Q4 2025.

  • Deutsche Bank reported no remaining Editas Medicine position as of Q4 2025 after selling out during the quarter.
  • Deutsche Bank sold 79,286 Editas Medicine shares in Q4 2025, an estimated $275K.
  • Deutsche Bank first reported a position in Editas Medicine in Q1 2016 and held it in 37 quarters.
  • Deutsche Bank's Editas Medicine position peaked at $23M in Q3 2018.
  • 196 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2025.

Based on Deutsche Bank's 13F filing for Q4 2025, filed 11 Feb 2026.